Montelukast Prescribing at SPRING HALL GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,549
Total Quantity
73.2K
NHS Cost
£3.6K
vs National Avg
+272.3%
SPRING HALL GROUP PRACTICE prescribed 2,549 items of Montelukast over the last 12 months at a cost of £3,602 to the NHS. This is 272.3% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
236
Jun 2026
202
Jun 2026
236
Jun 2026
208
Jun 2026
197
Jun 2026
212
Jun 2026
213
Jun 2026
221
Jun 2026
219
Jun 2026
195
Jun 2026
209
Jun 2026
201
Prescribing Details
| Total Items | 2,549 |
|---|---|
| Total Quantity | 73,205 |
| Total NHS Cost | £3,602 |
| Presentations | 4 different forms |
| vs National Average | +272.3% |
Montelukast Prescribing Comparison
| This practice | 2,549 items |
|---|---|
| National average per practice | 685 items |
| Difference | +272.3% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.